| ■ 영문 제목 : Global Immunology Drug Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K00064 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 105 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 면역억제제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (모노클로날 항체 (mAb), 항체 약물 복합체, 면역 억제제, 기타)와 용도별 시장규모 (병원, 클리닉, 암 연구 센터 및 연구소) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 면역억제제 시장 점유율 - 지역별 면역억제제 시장규모 - 주요지역의 종류별 시장규모 (모노클로날 항체 (mAb), 항체 약물 복합체, 면역 억제제, 기타) - 주요지역의 용도별 시장규모 (병원, 클리닉, 암 연구 센터 및 연구소) - 미주의 면역억제제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 면역억제제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 면역억제제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 면역억제제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 면역억제제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Abbott Laboratories, Active Biotech, Eli Lilly and Company, Autoimmune Inc., Pfizer, GlaxoSmithKline plc, Seattle Genetics, Genentech, F. Hoffmann-La Roche Ltd., Eisai Co., Bayer AG, Sanofi Aventis LLC. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Immunology Drug will have significant change from previous year. By the most conservative estimates of global Immunology Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Immunology Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Immunology Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Immunosuppressive medication
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Cancer Research Centers and Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
1 Scope of the Report 2 Executive Summary 3 Global Immunology Drug by Company 4 Immunology Drug by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Immunology Drug Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Immunology Drug Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Monoclonal Antibodies (mAb) Table 3. Major Players of Antibody Drug Conjugates Table 4. Major Players of Immunosuppressive medication Table 5. Major Players of Others Table 6. Global Immunology Drug Sales by Type (2016-2021) & (MT) Table 7. Global Immunology Drug Sales Market Share by Type (2016-2021) Table 8. Global Immunology Drug Revenue by Type (2016-2021) & ($ million) Table 9. Global Immunology Drug Revenue Market Share by Type (2016-2021) Table 10. Global Immunology Drug Sale Price by Type (2016-2021) Table 11. Global Immunology Drug Sales by Application (2016-2021) & (MT) Table 12. Global Immunology Drug Sales Market Share by Application (2016-2021) Table 13. Global Immunology Drug Value by Application (2016-2021) Table 14. Global Immunology Drug Revenue Market Share by Application (2016-2021) Table 15. Global Immunology Drug Sale Price by Application (2016-2021) Table 16. Global Immunology Drug Sales by Company (2019-2021) & (MT) Table 17. Global Immunology Drug Sales Market Share by Company (2019-2021) Table 18. Global Immunology Drug Revenue by Company (2019-2021) ($ Millions) Table 19. Global Immunology Drug Revenue Market Share by Company (2019-2021) Table 20. Global Immunology Drug Sale Price by Company (2019-2021) Table 21. Key Manufacturers Immunology Drug Producing Area Distribution and Sales Area Table 22. Players Immunology Drug Products Offered Table 23. Immunology Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Immunology Drug Sales by Region (2016-2021) (MT) Table 27. Global Immunology Drug Sales Market Share by Region (2016-2021) Table 28. Global Immunology Drug Revenue by Region (2016-2021) & ($ Millions) Table 29. Global Immunology Drug Revenue Market Share by Region (2016-2021) Table 30. Americas Immunology Drug Sales by Country (2016-2021) & (MT) Table 31. Americas Immunology Drug Sales Market Share by Country (2016-2021) Table 32. Americas Immunology Drug Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas Immunology Drug Revenue Market Share by Country (2016-2021) Table 34. Americas Immunology Drug Sales by Type (2016-2021) & (MT) Table 35. Americas Immunology Drug Sales Market Share by Type (2016-2021) Table 36. Americas Immunology Drug Sales by Application (2016-2021) & (MT) Table 37. Americas Immunology Drug Sales Market Share by Application (2016-2021) Table 38. APAC Immunology Drug Sales by Region (2016-2021) & (MT) Table 39. APAC Immunology Drug Sales Market Share by Region (2016-2021) Table 40. APAC Immunology Drug Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC Immunology Drug Revenue Market Share by Region (2016-2021) Table 42. APAC Immunology Drug Sales by Type (2016-2021) & (MT) Table 43. APAC Immunology Drug Sales Market Share by Type (2016-2021) Table 44. APAC Immunology Drug Sales by Application (2016-2021) & (MT) Table 45. APAC Immunology Drug Sales Market Share by Application (2016-2021) Table 46. Europe Immunology Drug Sales by Country (2016-2021) & (MT) Table 47. Europe Immunology Drug Sales Market Share by Country (2016-2021) Table 48. Europe Immunology Drug Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe Immunology Drug Revenue Market Share by Country (2016-2021) Table 50. Europe Immunology Drug Sales by Type (2016-2021) & (MT) Table 51. Europe Immunology Drug Sales Market Share by Type (2016-2021) Table 52. Europe Immunology Drug Sales by Application (2016-2021) & (MT) Table 53. Europe Immunology Drug Sales Market Share by Application (2016-2021) Table 54. Middle East & Africa Immunology Drug Sales by Country (2016-2021) & (MT) Table 55. Middle East & Africa Immunology Drug Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa Immunology Drug Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa Immunology Drug Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa Immunology Drug Sales by Type (2016-2021) & (MT) Table 59. Middle East & Africa Immunology Drug Sales Market Share by Type (2016-2021) Table 60. Middle East & Africa Immunology Drug Sales by Application (2016-2021) & (MT) Table 61. Middle East & Africa Immunology Drug Sales Market Share by Application (2016-2021) Table 62. Key and Potential Regions of Immunology Drug Table 63. Key Application and Potential Industries of Immunology Drug Table 64. Key Challenges of Immunology Drug Table 65. Key Trends of Immunology Drug Table 66. Immunology Drug Distributors List Table 67. Immunology Drug Customer List Table 68. Global Immunology Drug Sales Forecast by Region (2021-2026) & (MT) Table 69. Global Immunology Drug Consumption Market Forecast by Region Table 70. Global Immunology Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 71. Global Immunology Drug Revenue Market Share Forecast by Region (2021-2026) Table 72. Americas Immunology Drug Sales Forecast by Country (2021-2026) & (MT) Table 73. Americas Immunology Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 74. APAC Immunology Drug Sales Forecast by Region (2021-2026) & (MT) Table 75. APAC Immunology Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 76. Europe Immunology Drug Sales Forecast by Country (2021-2026) & (MT) Table 77. Europe Immunology Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Middle East & Africa Immunology Drug Sales Forecast by Country (2021-2026) & (MT) Table 79. Middle East & Africa Immunology Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Global Immunology Drug Sales Forecast by Type (2021-2026) & (MT) Table 81. Global Immunology Drug Sales Market Share Forecast by Type (2021-2026) Table 82. Global Immunology Drug Revenue Forecast by Type (2021-2026) & ($ Millions) Table 83. Global Immunology Drug Revenue Market Share Forecast by Type (2021-2026) Table 84. Global Immunology Drug Sales Forecast by Application (2021-2026) & (MT) Table 85. Global Immunology Drug Sales Market Share Forecast by Application (2021-2026) Table 86. Global Immunology Drug Revenue Forecast by Application (2021-2026) & ($ Millions) Table 87. Global Immunology Drug Revenue Market Share Forecast by Application (2021-2026) Table 88. Abbott Laboratories Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 89. Abbott Laboratories Immunology Drug Product Offered Table 90. Abbott Laboratories Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 91. Abbott Laboratories Main Business Table 92. Abbott Laboratories Latest Developments Table 93. Active Biotech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 94. Active Biotech Immunology Drug Product Offered Table 95. Active Biotech Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 96. Active Biotech Main Business Table 97. Active Biotech Latest Developments Table 98. Eli Lilly and Company Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 99. Eli Lilly and Company Immunology Drug Product Offered Table 100. Eli Lilly and Company Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 101. Eli Lilly and Company Main Business Table 102. Eli Lilly and Company Latest Developments Table 103. Autoimmune Inc. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 104. Autoimmune Inc. Immunology Drug Product Offered Table 105. Autoimmune Inc. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 106. Autoimmune Inc. Main Business Table 107. Autoimmune Inc. Latest Developments Table 108. Pfizer Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 109. Pfizer Immunology Drug Product Offered Table 110. Pfizer Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 111. Pfizer Main Business Table 112. Pfizer Latest Developments Table 113. GlaxoSmithKline plc Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 114. GlaxoSmithKline plc Immunology Drug Product Offered Table 115. GlaxoSmithKline plc Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 116. GlaxoSmithKline plc Main Business Table 117. GlaxoSmithKline plc Latest Developments Table 118. Seattle Genetics Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 119. Seattle Genetics Immunology Drug Product Offered Table 120. Seattle Genetics Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 121. Seattle Genetics Main Business Table 122. Seattle Genetics Latest Developments Table 123. Genentech Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 124. Genentech Immunology Drug Product Offered Table 125. Genentech Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 126. Genentech Main Business Table 127. Genentech Latest Developments Table 128. F. Hoffmann-La Roche Ltd. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 129. F. Hoffmann-La Roche Ltd. Immunology Drug Product Offered Table 130. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 131. F. Hoffmann-La Roche Ltd. Main Business Table 132. F. Hoffmann-La Roche Ltd. Latest Developments Table 133. Eisai Co. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 134. Eisai Co. Immunology Drug Product Offered Table 135. Eisai Co. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 136. Eisai Co. Main Business Table 137. Eisai Co. Latest Developments Table 138. Bayer AG Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 139. Bayer AG Immunology Drug Product Offered Table 140. Bayer AG Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 141. Bayer AG Main Business Table 142. Bayer AG Latest Developments Table 143. Sanofi Aventis LLC. Basic Information, Immunology Drug Manufacturing Base, Sales Area and Its Competitors Table 144. Sanofi Aventis LLC. Immunology Drug Product Offered Table 145. Sanofi Aventis LLC. Immunology Drug Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E) Table 146. Sanofi Aventis LLC. Main Business Table 147. Sanofi Aventis LLC. Latest Developments List of Figures Figure 1. Picture of Immunology Drug Figure 2. Immunology Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Immunology Drug Sales Growth Rate 2016-2026 (MT) Figure 7. Global Immunology Drug Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Immunology Drug Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Monoclonal Antibodies (mAb) Figure 10. Product Picture of Antibody Drug Conjugates Figure 11. Product Picture of Immunosuppressive medication Figure 12. Product Picture of Others Figure 13. Global Immunology Drug Sales Market Share by Type in 2020 Figure 14. Global Immunology Drug Revenue Market Share by Type (2016-2021) Figure 15. Immunology Drug Consumed in Hospitals Figure 16. Global Immunology Drug Market: Hospitals (2016-2021) & (MT) Figure 17. Immunology Drug Consumed in Clinics Figure 18. Global Immunology Drug Market: Clinics (2016-2021) & (MT) Figure 19. Immunology Drug Consumed in Cancer Research Centers and Institutes Figure 20. Global Immunology Drug Market: Cancer Research Centers and Institutes (2016-2021) & (MT) Figure 21. Global Immunology Drug Sales Market Share by Application (2016-2021) Figure 22. Global Immunology Drug Revenue Market Share by Application in 2020 Figure 23. Immunology Drug Revenue Market by Company in 2020 ($ Million) Figure 24. Global Immunology Drug Revenue Market Share by Company in 2020 Figure 25. Global Immunology Drug Sales Market Share by Regions (2016-2021) Figure 26. Global Immunology Drug Revenue Market Share by Region in 2020 Figure 27. Americas Immunology Drug Sales 2016-2021 (MT) Figure 28. Americas Immunology Drug Revenue 2016-2021 ($ Millions) Figure 29. APAC Immunology Drug Sales 2016-2021 (MT) Figure 30. APAC Immunology Drug Revenue 2016-2021 ($ Millions) Figure 31. Europe Immunology Drug Sales 2016-2021 (MT) Figure 32. Europe Immunology Drug Revenue 2016-2021 ($ Millions) Figure 33. Middle East & Africa Immunology Drug Sales 2016-2021 (MT) Figure 34. Middle East & Africa Immunology Drug Revenue 2016-2021 ($ Millions) Figure 35. Americas Immunology Drug Sales Market Share by Country in 2020 Figure 36. Americas Immunology Drug Revenue Market Share by Country in 2020 Figure 37. Americas Immunology Drug Sales Market Share by Type in 2020 Figure 38. Americas Immunology Drug Sales Market Share by Application in 2020 Figure 39. United States Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 40. Canada Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 41. Mexico Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 42. Brazil Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 43. APAC Immunology Drug Sales Market Share by Region in 2020 Figure 44. APAC Immunology Drug Revenue Market Share by Regions in 2020 Figure 45. APAC Immunology Drug Sales Market Share by Type in 2020 Figure 46. APAC Immunology Drug Sales Market Share by Application in 2020 Figure 47. China Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 48. Japan Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 49. Korea Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 50. Southeast Asia Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 51. India Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 52. Australia Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 53. Europe Immunology Drug Sales Market Share by Country in 2020 Figure 54. Europe Immunology Drug Revenue Market Share by Country in 2020 Figure 55. Europe Immunology Drug Sales Market Share by Type in 2020 Figure 56. Europe Immunology Drug Sales Market Share by Application in 2020 Figure 57. Germany Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 58. France Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 59. UK Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 60. Italy Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 61. Russia Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 62. Middle East & Africa Immunology Drug Sales Market Share by Country in 2020 Figure 63. Middle East & Africa Immunology Drug Revenue Market Share by Country in 2020 Figure 64. Middle East & Africa Immunology Drug Sales Market Share by Type in 2020 Figure 65. Middle East & Africa Immunology Drug Sales Market Share by Application in 2020 Figure 66. Egypt Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 67. South Africa Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 68. Israel Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 69. Turkey Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 70. GCC Country Immunology Drug Revenue Growth 2016-2021 ($ Millions) Figure 71. Channels of Distribution Figure 72. Distributors Profiles |
| ※본 조사보고서 [세계의 면역억제제 시장예측 2021년-2026년] (코드 : LPI-2201K00064) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 면역억제제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |